CNTG(Delisted)
CentogeneยทNASDAQ
--
--(--)
CNTG Profile
Centogene N.V.
A commercial-stage essential biodata life science partner for rare and neurodegenerative diseases
Am Strande 7, 18055 Rostock, Germany
--
Centogene N.V. was incorporated under the laws of the Netherlands on October 11, 2018. The company provides data-driven answers for patients, physicians and pharmaceutical companies with rare and neurodegenerative diseases. The company combines multi-omics technology with CENTOGENE Biodatabank to enable comprehensive analysis to guide precision medicine. The company's unique approach enables rapid and reliable diagnosis for patients, supports physicians to more accurately understand disease states, and accelerates and reduces the risk of targeted drug discovery, development and commercialization. The company's business includes providing solutions for physicians and their patients as well as biopharmaceutical companies, including through partnerships with contract research organizations.
